Galmed Pharmaceuticals Ltd.

GLMD XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

4.6M

Short interest (May 15)

0.9%

Net Short (Jun 03 ): 0.0%

Borrow Fee

82.13%

↓ 1.1%

Available Shares

800K

↓ 1.8%

Price Chart

Company Overview

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Company Info

Exchange: NASDAQ

CIK: 0001595353

Asset Type: CS

Market Data

Market Cap: $4,561,020

Employees: 6

Status: Active

Short Interest

Current Borrow Fee 82.13%

Range: 82.13% - 82.13%

Available Shares 800K

Range: 500K - 750K

Recent Changes

Fee Change: ↑ 1.0%

Available Change: ↑ 11.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime